SCHEMBL4846963

SCHEMBL4846963

COc1ccc(C(=O)C=Cc2cccc(OCCN(C)C)c2)c(OC)c1OC

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 3/20 0.56
CYP1A2 P05177 2/20 0.53
CYP1A1 P04798 1/20 0.53
CYP1B1 Q16678 1/20 0.53
MCL1 Q07820 3/20 0.53
CYP3A4 P08684 2/20 0.52
APP P05067 2/20 0.52
BCHE P06276 2/20 0.50
ACHE P22303 2/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
ABCG2 Q9UNQ0 2/20 0.49
NR1H4 Q96RI1 2/20 0.48
KCNA3 P22001 1/20 0.48
ALDH1A1 P00352 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4852528 0.95 TUBB1 (0.55) TUBB1CYP1A2CYP1A1CYP1B1MCL1
SCHEMBL7197222 0.88 TUBB1 (0.58) TUBB1CYP1A2CYP1A1CYP1B1MCL1
SCHEMBL7197219 0.88 TUBB1 (0.58) TUBB1CYP1A2CYP1A1CYP1B1MCL1
SCHEMBL4852282 0.87 TUBB1 (0.58) TUBB1CYP1A2CYP1A1CYP1B1MCL1
SCHEMBL4845309 0.87 ABCG2 (0.60) CYP1A2CYP3A4APPBCHEACHE
SCHEMBL4854115 0.87 MAPT (0.63) CYP1A2CYP1A1CYP1B1CYP3A4APP
SCHEMBL4851228 0.87 ABCG2 (0.60) CYP1A2CYP3A4APPBCHEACHE
SCHEMBL4848357 0.86 MAOB (0.60) CYP1A2CYP3A4APPBCHEACHE
SCHEMBL30736488 0.85 TUBB1 (0.69) TUBB1CYP1A2CYP1A1CYP1B1MCL1
SCHEMBL31436339 0.85 TUBB1 (0.69) TUBB1CYP1A2CYP1A1CYP1B1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed